RPG Life Sciences share news and announcements

NSE: RPGLIFEBSE: 532983Pharmaceuticals & BiotechnologySmall Cap

₹2,619.60₹160.60 (5.78%)BSE ₹2,618.15

Share price at the NSE close on 23 Oct 2026. Previous close ₹2,780.20.

52-week range of traded prices to 23 Oct 2026

₹1,733.00Low, 23 Mar 2026₹3,127.80High, 25 Sep 2026

Next results date: the board meets on 29 Oct 2026 to consider: financial results.

Market cap: ₹4,333 Cr923rd largest listed
P/E: 36.3
P/B: 7.2
Dividend yield: 0.92%
ROE: 21.0%
ROCE: 21.3%
Debt to equity: 0.03
Volume, NSE: 19,53144.4% delivered

RPG Life Sciences board meetings

120 filed, newest first. Page 1 of 3.

Oct 2026
- 22 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2026 (opens in a new tab)
Jul 2026
- 21 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2026 (opens in a new tab)
Apr 2026
- 22 Apr · Board meeting
  To consider and approve the financial results for the period ended March 31, 2026 and dividend (opens in a new tab)
Jan 2026
- 27 Jan · Board meeting
  Board meeting held on January 27, 2026. (opens in a new tab)
- 20 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2025 (opens in a new tab)
Dec 2025
- 15 Dec · Board meeting
  Outcome of Board meeting held on December 15, 2025 (opens in a new tab)
Oct 2025
- 17 Oct · Board meeting
  Board meeting held on October 17, 2025. (opens in a new tab)
- 10 Oct · Board meeting
  RPG Life Sciences Limited informed that the meeting of the Board of Directors of the Company is scheduled on 17/10/2025 to consider and approve Unaudited Financial Results for the quarter and half year ended September 30, 2025. (opens in a new tab)
Jul 2025
- 18 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2025 (opens in a new tab)
Apr 2025
- 21 Apr · Board meeting
  Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Monday, April 28, 2025, inter-alia, to: 1. Consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2025.2. Recommend dividend, if any, on Equity Shares of the Company for the financial year ended March 31, 2025. Further, pursuant to the Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives, is closed from April 1, 2025 and will continue to remain closed till 48 hours after declaration of results on April 28, 2025. (opens in a new tab)
Jan 2025
- 24 Jan · Board meeting
  We wish to inform you that the Board of Directors of the Company has at its meeting held on Friday, January 24, 2025, inter-alia, considered and approved the 1. Unaudited Financial Results of the Company for the quarter ended December 31, 2024 and Intimation about change in Code/Policy. (opens in a new tab)
- 17 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2024 (opens in a new tab)
Nov 2024
- 7 Nov · Board meeting
  Outcome of Board Meeting held on November 07, 2024. (opens in a new tab)
- 7 Nov · Board meeting
  Board meeting held on November 07, 2024. (opens in a new tab)
Oct 2024
- 31 Oct · Board meeting
  To consider and approve the unaudited financial results for the period ended September 30, 2024 (opens in a new tab)
Sep 2024
- 13 Sep · Board meeting
  Board meeting held on September 13, 2024. (opens in a new tab)
Jul 2024
- 19 Jul · Board meeting
  We wish to inform you that the Board of Directors of the Company has at its meeting held on Friday, July 19, 2024, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2024. The said Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.The meeting commenced at 03:00 p.m. and concluded at 5.45 p.m.Kindly take the above on record. (opens in a new tab)
- 12 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2024 (opens in a new tab)
Apr 2024
- 23 Apr · Board meeting
  Audited Financial Results for the quarter and year ended March 31, 2024 and to consider and recommend dividend on equity shares , if any, for the year ended March 31, 2024 (opens in a new tab)
Feb 2024
- 1 Feb · Board meeting
  Outcome of Board Meeting held on February 01, 2024. (opens in a new tab)
- 1 Feb · Board meeting
  We wish to inform you that the Board of Directors of the Company has at its meeting held on Thursday, February 01, 2024, inter-alia Considered and approved items as mentioned in attachment.The meeting commenced at 02:00 p.m. and concluded at 05.30 p.m.Kindly take the above on record. (opens in a new tab)
Jan 2024
- 25 Jan · Board meeting
  To consider and approve the financial results for the quarter and nine months ended December 31, 2023 (opens in a new tab)
Oct 2023
- 18 Oct · Board meeting
  We wish to inform you that the Board of Directors of the Company has at its meeting held on Wednesday, October 18, 2023, inter-alia: 1.considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023. 2.Execution of Power Delivery Agreement with Sunpound Solar Private Limited (Sunpound) a Special Purpose Vehicle (SPV), for supply of electricity by Power Producer to the Company, by setting up a group captive solar power project in Maharashtra. Details required as per SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1 /P/CI R/2023/123 dated July 13, 2023 are enclosed as Annexure - A. The meeting commenced at 03:00 p.m. and concluded at 06.00 p.m.Kindly take the above on record. (opens in a new tab)
- 11 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2023 (opens in a new tab)
Jul 2023
- 28 Jul · Board meeting
  Board meeting held on July 28, 2023. (opens in a new tab)
- 21 Jul · Board meeting
  Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Friday, July 28, 2023, inter-alia, to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2023.Further, pursuant to the 'Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders' of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives, is closed from July 1, 2023 and will continue to remain closed till 48 hours after the results are made public on July 28, 2023. Kindly take this information on record. (opens in a new tab)
Apr 2023
- 21 Apr · Board meeting
  Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Friday, April 28, 2023, inter-alia, to: 1. Consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2023.2. Recommend dividend, if any, on Equity Shares of the Company for the financial year ended March 31, 2023. Further, pursuant to the Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives, is closed from April 1, 2023 and will continue to remain closed till 48 hours after declaration of results on April 28, 2023.Kindly take this information on record. (opens in a new tab)
Feb 2023
- 1 Feb · Board meeting
  We wish to inform you that the Board of Directors of the Company has at its meeting held on Wednesday, February 01, 2023, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022. The said Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.The meeting commenced at 03:00 p.m. and concluded at 5.15 p.m.Kindly take the above on record. (opens in a new tab)
Jan 2023
- 25 Jan · Board meeting
  Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Wednesday, February 01, 2023, inter-alia, to consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31, 2022. Further, pursuant to the Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives, is closed from January 01, 2023 and will continue to remain closed till 48 hours after the results are made public on February 01, 2023.Kindly take this information on record. (opens in a new tab)
Oct 2022
- 17 Oct · Board meeting
  Board Meeting held on 17-Oct-2022 to consider financial statements for the period ended September 2022 (opens in a new tab)
- 10 Oct · Board meeting
  Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Monday, October 17, 2022, inter-alia, to consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2022. Further, pursuant to the Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives, is closed from October 1, 2022 and will continue to remain closed till 48 hours after the results are made public on October 17, 2022.Kindly take this information on record. (opens in a new tab)
Aug 2022
- 2 Aug · Board meeting
  33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has, at its meeting held on Tuesday, August 02, 2022, inter alia, considered and approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2022 along with Limited Review Report of the Statutory Auditors thereon.The meeting commenced at 03:00 p.m. and concluded at 06:00 p.m.Kindly take the same on your record. (opens in a new tab)
Jul 2022
- 26 Jul · Board meeting
  Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Tuesday, August 2, 2022, inter-alia, to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2022. Further, pursuant to the Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives, is closed from July 1, 2022 and will continue to remain closed till 48 hours after the results are made public on August 2, 2022.Kindly take this information on record. (opens in a new tab)
Apr 2022
- 29 Apr · Board meeting
  Recommended equity dividend of Rs. 9.60 per share of Rs. 8/- each (120%) for the financial year ended March 31, 2022, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting. (opens in a new tab)
- 29 Apr · Board meeting
  Outcome of the meeting of the Board of Directors of RPG Life Sciences Limited held on April 29, 2022, in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.The Board meeting commenced at 3.00 p.m. and concluded at 6.00 p.m. (opens in a new tab)
- 22 Apr · Board meeting
  Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Friday, April 29, 2022, inter-alia, to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2022. Further, pursuant to the Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives, is closed from April 1, 2022 and will continue to remain closed till 48 hours after the results are made public on April 29, 2022.Kindly take this information on record. (opens in a new tab)
Jan 2022
- 25 Jan · Board meeting
  Board meeting held on January 25, 2022. (opens in a new tab)
- 18 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2021 (opens in a new tab)
Oct 2021
- 29 Oct · Board meeting
  Board meeting held on October 29, 2021. (opens in a new tab)
- 18 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2021 (opens in a new tab)
Jul 2021
- 28 Jul · Board meeting
  Board meeting held on July 28, 2021. (opens in a new tab)
- 21 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2021 (opens in a new tab)
Apr 2021
- 30 Apr · Board meeting
  Board meeting held on April 30, 2021. (opens in a new tab)
- 23 Apr · Board meeting
  For approval of Audited Financial Results for the Quarter and Year ended March 31, 2021. (opens in a new tab)
Jan 2021
- 25 Jan · Board meeting
  Board meeting held on January 25, 2021. (opens in a new tab)
- 18 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2020 (opens in a new tab)
Oct 2020
- 30 Oct · Board meeting
  Board meeting held on October 30, 2020. (opens in a new tab)
- 23 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2020 (opens in a new tab)
Jul 2020
- 31 Jul · Board meeting
  Board meeting held on July 31, 2020. (opens in a new tab)
- 24 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2020 (opens in a new tab)

RPG Life Sciences board meetings

Oct 2026

Jul 2026

Apr 2026

Jan 2026

Dec 2025

Oct 2025

Jul 2025

Apr 2025

Jan 2025

Nov 2024

Oct 2024

Sep 2024

Jul 2024

Apr 2024

Feb 2024

Jan 2024

Oct 2023

Jul 2023

Apr 2023

Feb 2023

Jan 2023

Oct 2022

Aug 2022

Jul 2022

Apr 2022

Jan 2022

Oct 2021

Jul 2021

Apr 2021

Jan 2021

Oct 2020

Jul 2020